Evidence is increasing that disturbances in the gut microbiome may play a significant role in
the etiology of obesity and type 2 diabetes. The short chain fatty acid butyrate, a major end …

Cardiovascular diseases (CVD) are major causes of death worldwide. Recently, new roles
for intestinal microbiota in pathology and treatment of CVD have been proposed. Butyrate, a …

Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide.
Metabolic dysfunction is a fundamental core mechanism underlying CVDs. Previous studies …

Postbiotics are defined as “preparation of inanimate microorganisms and/or their
components that confers a health benefit on the host”. Postbiotics have unique advantages …

Background There is considerable research value and extensive application perspectives to
explore the link between gut microbiota and heart failure. The purpose of this study is to …

High fat diet (HFD) is a risk factor for metabolic syndrome which is characterized by overt
glucose dysmetabolism and tissue derangement. The liver and pancreas are important …

Fatty liver is the hepatic consequence of chronic insulin resistance (IR) and related
syndromes. It is mostly accompanied by inflammatory and oxidative molecules. Increased …

Increased inflammation is found in cardiac sympathetic neural remodeling with malignant
ventricular arrhythmia (VA) following myocardial infarction (MI). Butyrate, as a microbiota …

Polycystic ovarian syndrome (PCOS) is a known endocrine disorder that has affected many
women of childbearing age, and is accompanied by various neurodegenerative conditions …

Cardiac fibrosis is an integral aspect of every form of cardiovascular diseases, which is one
of the leading causes of death worldwide. It is urgent to explore new effective drugs and …